Reading the tape
NASDAQ: GCTK
GlucoTrack, Inc.
Healthcare · Medical - Instruments & Supplies
Market Cap
$418.50K
52w High
$15.90
52w Low
$0.62
P/E
-0.03
Volume
606.36K
Outstanding Shares
567.46K
Price vs Fundamentals
Why The Stock Is Moving
Likely fundamental deteriorationModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -93.48%FCF (TTM): -21.77%
What changed
The stock fell 93.48% over the last year. Free cash flow declined 21.77% over the trailing twelve months.
What the market seems to be pricing
The market appears to be responding to weaker operating momentum rather than only rerating the stock.
What would invalidate this read
Free cash flow fell 21.77% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
CEOPaul V. Goode
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees11
IPO dateApr 25, 2013
Valuation
Forward P/E—
EV/EBITDA0.24
Enterprise value-$3.87M
Stock splits
Jun 16, 2025↓ Reverse
Every 60 shares became 1
May 20, 2024↓ Reverse
Every 5 shares became 1
Aug 13, 2021↓ Reverse
Every 13 shares became 1
Profitability & growth
Revenue growth—
Gross margin0%
Operating margin0%
ROE-685.57%▼494.41%vs FY2024
Analyst consensus
Rating—
Target price—
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Mar 30, 2026
Q2 FY26 · EPS est — · Revenue est —
View